1. Home
  2. HLI vs SYRE Comparison

HLI vs SYRE Comparison

Compare HLI & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

N/A

Current Price

$124.95

Market Cap

9.7B

Sector

Finance

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$102.40

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HLI
SYRE
Founded
1972
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.5B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
HLI
SYRE
Price
$124.95
$102.40
Analyst Decision
Buy
Strong Buy
Analyst Count
7
12
Target Price
$194.29
$85.08
AVG Volume (30 Days)
942.1K
942.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
1.54%
N/A
EPS Growth
6.87
N/A
EPS
1.15
N/A
Revenue
$2,617,516,000.00
N/A
Revenue This Year
$13.77
N/A
Revenue Next Year
$12.10
N/A
P/E Ratio
$107.09
N/A
Revenue Growth
9.55
N/A
52 Week Low
$112.83
$14.51
52 Week High
$211.78
$108.14

Technical Indicators

Market Signals
Indicator
HLI
SYRE
Relative Strength Index (RSI) 38.88 55.31
Support Level $112.83 $92.37
Resistance Level $144.92 $104.07
Average True Range (ATR) 5.29 5.63
MACD -0.97 -0.22
Stochastic Oscillator 38.13 63.06

Price Performance

Historical Comparison
HLI
SYRE

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: